TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis
Transjugular Intrahepatic Portosystemic Shunt (TIPS) Using Covered Stents Combined With Variceal Embolization in the Prevention of Variceal Rebleeding for Patients With Cirrhosis : a Prospective, Open-labeled, Randomized, Controlled Trial
1 other identifier
interventional
134
1 country
2
Brief Summary
The purpose of this study is to determine whether TIPS combined with variceal embolization are effective in the prevention of variceal rebleeding in patients with liver cirrhosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2014
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2014
CompletedFirst Posted
Study publicly available on registry
April 22, 2014
CompletedStudy Start
First participant enrolled
June 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2020
CompletedOctober 25, 2022
October 1, 2022
6.4 years
April 17, 2014
October 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All-cause rebleeding
2 years
Secondary Outcomes (6)
Variceal rebleeding
2 years
Shunt dysfunction
2 years
Hepatic encephalopathy
2 years
Liver function changs
2 years
Mortality
2 years
- +1 more secondary outcomes
Study Arms (2)
TIPS combined with variceal embolization
EXPERIMENTALThe covered stents will be used for TIPS The gastroesophageal collaterals will be embolized during the procedure of TIPS
TIPS alone
ACTIVE COMPARATORThe covered stents will be used for TIPS No embolization of any collateral will be performed during TIPS
Interventions
TIPS will be performed with a standard technique. TIPS revision will be planned if any evidence of shunt dysfunction is observed.
Embolization of gastroesophageal collaterals will be conducted via the same jugular vein before TIPS implantation. The major procedures includ (a) angiography of gastroesophageal collaterals after successful intrahepatic puncture of a branch of the portal vein and (b) embolization of gastroesophageal collaterals with coils of varying diameters, which result in the gastroesophageal collaterals disappearing at postembolization angiography.
Eligibility Criteria
You may qualify if:
- Signed written informed consent
- Dignosis of cirrhosis (clinical or by liver biopsy)
- Admission due to variceal bleeding occurred 5 to 42 days prior and standard treatment for secondary prophylaxis failed
- Age 18 to 75 years
You may not qualify if:
- Hepatic carcinoma and/or other malignancy diseases
- Portal vein thrombosis (≥50% of the lumen)
- Child-Pugh score\>13 points
- Spontaneous recurrent hepatic encephalopathy
- Budd-Chiari syndrome
- Large spontaneous portosystemic shunts
- Sepsis
- Spontaneous bacterial peritonitis
- Uncontrollable hypertension
- Serious cardiac or pulmonary dysfunction
- Renal failure
- With TIPS contraindications
- Previous TIPS or collateral embolization,
- Pregnancy or breast-feeding
- History of organ transplantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Xijing Hospital of digestive disease, Fourth Military Medical University
Xi'an, Shaanxi, 710032, China
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
Xi'an, Shaanxi, 710032, China
Related Publications (1)
Lv Y, Chen H, Luo B, Bai W, Li K, Wang Z, Xia D, Guo W, Wang Q, Li X, Yuan J, Cai H, Xia J, Yin Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trial. Lancet Gastroenterol Hepatol. 2022 Aug;7(8):736-746. doi: 10.1016/S2468-1253(22)00087-5. Epub 2022 May 17.
PMID: 35588750DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guohong Han, PhD & MD
Xijing Hospital of Digestive Diseases, Fourth Military Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Ph.D.
Study Record Dates
First Submitted
April 17, 2014
First Posted
April 22, 2014
Study Start
June 16, 2014
Primary Completion
November 20, 2020
Study Completion
November 20, 2020
Last Updated
October 25, 2022
Record last verified: 2022-10